Aurobindo Pharma Acquires US-Based A1 Biochem Labs LLC for USD 15.247 Mn
Aurobindo Pharma Ltd 路 Others (Uncategorized) 路 02 Oct 2026, 11:39 pm
Aurobindo Pharma Acquires US-Based A1 Biochem Labs LLC for USD 15.247 Mn Aurobindo Pharma's step-down subsidiary, A1 Biochem USA Inc, acquired 100% ownership of US-based A1 Biochem Labs LLC for a cash consideration of USD 15.247 Mn on 2nd Oct'26. The target provides contract research and chemistry services, reporting revenues of USD 6.35 Mn, USD 9.23 Mn, and USD 5.92 Mn across CY23, CY24, and CY25, respectively. The transaction bolsters Aurobindo鈥檚 front-end R&D capabilities, enabling the creation of an integrated CRDMO platform alongside its existing large-scale API manufacturing business.
Original exchange filing (PDF)
More announcements from Aurobindo Pharma Ltd
- Intimation of classification of US FDA inspection at Lannet Company LLC, a wholly owned subsidiary of Aurobindo Pharma USA Inc., a wholly owned subsidiary of the Company. 路 12 Nov 2026
- Submission of Earning Call Transcript for Q2FY27. 路 11 Nov 2026
- Unit-2 of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company received Establishment Inspection Report from US FDA with classification as "Voluntary Action Indicated". 路 11 Nov 2026
- Intimation of investors / analysts meet to be held on 17.11.2026. 路 09 Nov 2026
- Intimation of investor / analysts meet to be held on 16.09.2026. 路 09 Nov 2026
- Submission of Financial results for the Quarter and Half year ended September 30, 2026. 路 05 Nov 2026
- Reappointment of Mr. M. R. Kumar as Independent Director of the Company for second term with effect from April 1, 2027. 路 05 Nov 2026
- Transfer of ownership of Auro Pharma LLC, Russia from Auroactive Pharma Private Limited to Auropharm Overseas Limited, Wholly Owned subsidiaries of the Company. 路 05 Nov 2026
